Health
Pfizer to price Covid drug Paxlovid at $1,390 per course
Paxlovid, Pfizer’s antiviral medication to treat the coronavirus disease, is displayed in this picture taken on Oct. 7, 2022. Wolfgang Rattay | Reuters Pfizer will price a five-day course of its Covid antiviral drug Paxlovid at $1,390 when the company starts to transition it to the commercial market later this year. A company spokesperson on […]
Read More
Amazon begins delivering medications by drone in Texas
Amazon announced Friday it will soon begin making drone deliveries in College Station, Texas. Amazon Amazon Pharmacy customers located in College Station, Texas can now have their prescription medications delivered by drone, the company announced in a blog post Wednesday. Eligible customers can access more than 500 medications, including treatments for common conditions like asthma […]
Read More
FDA proposes ban on hair relaxers with formaldehyde
The Food and Drug Administration is proposing a ban on using formaldehyde as an ingredient in hair relaxers, a huge step in raising awareness about the potential harms such products create for the many Black women who typically use them. The proposed rule would ban the chemical in hair-smoothing or hair-straightening products, also called relaxers. The FDA […]
Read More
Johnson & Johnson beats on earnings and hikes outlook as medtech, pharmaceutical sales surge
An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. Mark Ralston | AFP | Getty Images Johnson & Johnson on Tuesday reported adjusted earnings and revenue that topped Wall Street’s expectations, driven by a surge in sales in the company’s medical devices and pharmaceutical business divisions. […]
Read More
Pfizer gets upgrade at Jefferies, which says there’s a buying opportunity in the pharma giant’s stock
Jefferies thinks it’s time for investors to go long on Pfizer . The firm upgraded the pharmaceutical stock to buy from hold in a Monday note and increased its price target to $39 per share from $38. Jefferies’ forecast calls for roughly 21% upside from Friday’s $32.11 close. Analyst Akash Tewari said that while the […]
Read More
UBS upgrades this ‘core’ health-care stock, sees nearly 20% upside
UBS thinks UnitedHealth is an essential portfolio holding trading at a discount. The firm upgraded shares of the health-care giant to buy from neutral and raised its target price to $640 from $520. UBS’ forecast implies roughly 19% upside from Friday’s $539.40 close. Analyst A.J. Rice labeled the stock as “a core holding available at […]
Read More
Rite Aid files for bankruptcy amid slowing sales, opioid litigation
A Rite Aid store stands in Brooklyn on August 28, 2023 in New York City. Spencer Platt | Getty Images Rite Aid filed for Chapter 11 bankruptcy protection in New Jersey on Sunday and said it would begin restructuring to significantly reduce its debt. The company appointed Jeffrey Stein as its new chief executive officer […]
Read More
When is it OK to violate your cost basis to buy more shares of a company?
Here’s our Club Mailbag email [email protected] — so you send your questions directly to Jim Cramer and his team of analysts. We can’t offer personal investing advice. We will only consider more general questions about the investment process or stocks in the portfolio or related industries. This week’s question: The cardinal rule of discipline is […]
Read More
Many are betting Ozempic will reduce the need for knee surgery. What it means if they’re wrong
Medical device stocks of all kinds were pummeled over the past week as investors tried to calculate the ripple effects of new weight loss drugs. It wasn’t the first rout in the sector — the pressure has persisted for several months. The fear has been that whenever you have a large group of consumers changing […]
Read More
Pfizer slashes full-year earnings and revenue guidance as Covid treatment, vaccine sales slump
Pfizer CEO Albert Bourla talks during a press conference with the president of the European Commission after a visit to oversee the production of the Pfizer-BioNTech Covid-19 vaccine at the factory of U.S. pharmaceutical company Pfizer, in Puurs, Belgium, April 23, 2021. John Thys | AFP | Getty Images Pfizer slashed its full-year earnings and […]
Read More